cladribine has been researched along with Lymphoma, B-Cell in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (26.09) | 18.2507 |
| 2000's | 13 (56.52) | 29.6817 |
| 2010's | 3 (13.04) | 24.3611 |
| 2020's | 1 (4.35) | 2.80 |
| Authors | Studies |
|---|---|
| Ahn, IE; Calvo, KR; Francischetti, IMB; Kreitman, RJ; Obiorah, IE; Raffeld, M; Wang, HW; Wang, W; Wiestner, A | 1 |
| Fujita, Y; Fukushima, T; Iwao, H; Kawanami, T; Kishi, S; Masaki, Y; Miki, M; Miyazono, T; Murakami, J; Nakajima, A; Nakamura, T; Okazaki, T; Otsuki, N; Sakai, T; Sakamaki, I; Satoh, T; Tanaka, M; Ueda, T; Urasaki, Y | 1 |
| Itoh, K; Kasai, M; Maruyama, D; Matsuno, Y; Matsusako, M; Mori, S; Morishima, Y; Nakamura, S; Nakata, M; Nawano, S; Ogura, M; Ohashi, Y; Tanimoto, K; Terauchi, T; Tobinai, K; Usui, N; Watanabe, T | 1 |
| Ishitsuka, K; Katayose, K; Kimura, N; Ogata, K; Sasaki, H; Suzumiya, J; Takamatsu, Y; Tamura, K | 1 |
| Hotta, T; Kinoshita, T; Kosugi, H; Kusumoto, S; Matsuda, S; Motoji, T; Nagai, H; Ogura, M; Ohnishi, K; Ohyashiki, K; Omachi, K; Takahashi, N; Takayama, N; Yamaguchi, M | 1 |
| Che, Y; Christopherson, RI; Henrich, S; Kohnke, PL; Mactier, S | 1 |
| Golf, A; Haferlach, T; Hiddemann, W; Lenz, G; Rüdiger, T | 1 |
| Choi, I; Nakashima, Y; Shimada, T; Uike, N; Yamada, Y; Yufu, Y | 1 |
| Góra-Tybor, J; Jamroziak, K; Kordek, R; Majos, A; Rieske, P; Robak, P; Robak, T; Tybor, K; Urbańska-Ryś, H | 1 |
| Chou, T; Kasai, M; Kobayashi, Y; Matsuno, Y; Miura, I; Mori, S; Morishima, Y; Murayama, T; Nakamura, S; Ogura, M; Ohashi, Y; Sugai, S; Tobinai, K; Uike, N | 1 |
| Jäger, G; Linkesch, W; Neumeister, P; Quehenberger, F; Raderer, M; Wöhrer, S | 1 |
| Bontemps, F; Ferrant, A; Lisart, S; Smal, C; van den Neste, E | 1 |
| Inamoto, Y; Ito, M; Kodera, Y; Kuwatsuka, Y; Miyamura, K; Murase, T; Oba, T; Suzuki, R; Terakura, S; Tokunaga, M; Tsujimura, A | 1 |
| Ceglarek, B; Czyz, J; Federowicz, I; Holowiecki, J; Kalinka-Warzocha, E; Lech-Maranda, E; Robak, T; Wajs, J; Walewski, J; Warzocha, K | 1 |
| Alexanian, R; Daliani, D; Weber, DM | 1 |
| Piro, LD | 1 |
| Piro, LD; Saven, A | 1 |
| Christopherson, RI; Mulligan, SP; Szabados, E; Wilson, PK | 1 |
| Hoffman, M; Lesser, M; Rai, K; Xu, JC | 1 |
| Louie, D; Michaeli, J; Niesvizky, R; Zhu, AX | 1 |
| François, S; Grosbois, B; Hermine, O; Lefrère, F; Misset, JL; Panelatti, G; Troussard, X; Valensi, F; Varet, B | 1 |
| Bartkowiak, J; Błonski, JZ; Kasznicki, M; Kordek, R; Robak, T; Wawrzyniak, E | 1 |
| Boehrer, S; Chow, KU; Hoelzer, D; Mitrou, PS; Rummel, MJ; Schneider, B; Seipelt, G; Sommerlad, WD; Weidmann, E | 1 |
2 review(s) available for cladribine and Lymphoma, B-Cell
| Article | Year |
|---|---|
Cladribine in the treatment of low-grade non-Hodgkin's lymphoma.
Topics: Antineoplastic Agents; Cladribine; Clinical Trials as Topic; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Cutaneous; Skin Neoplasms; Waldenstrom Macroglobulinemia | 1996 |
2-Chlorodeoxyadenosine treatment of lymphoma.
Topics: Adenosine Deaminase; Antimetabolites, Antineoplastic; Antineoplastic Agents; Cladribine; Humans; Lymphoma; Lymphoma, B-Cell; Lymphoma, T-Cell, Cutaneous; Pentostatin; Vidarabine; Waldenstrom Macroglobulinemia | 1996 |
7 trial(s) available for cladribine and Lymphoma, B-Cell
| Article | Year |
|---|---|
Prospective clinical study of R-CMD therapy for indolent B cell lymphoma and mantle cell lymphoma from the Hokuriku Hematology Oncology Study Group.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Dexamethasone; Female; Humans; Lymphoma, B-Cell; Lymphoma, Mantle-Cell; Male; Middle Aged; Mitoxantrone; Prospective Studies; Rituximab | 2015 |
Phase I/II and pharmacokinetic study of cladribine with 2-h infusion in Japanese patients with relapsed indolent B-cell lymphoma mostly pretreated with rituximab.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Dose-Response Relationship, Drug; Female; Humans; Infusions, Intravenous; Lymphoma, B-Cell; Male; Middle Aged; Recurrence; Rituximab | 2009 |
Cladribine combined with rituximab (R-2-CdA) therapy is an effective salvage therapy in relapsed or refractory indolent B-cell non-Hodgkin lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Cladribine; Female; Humans; Immunologic Factors; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Rituximab; Salvage Therapy; Time Factors; Treatment Outcome | 2011 |
Durable response but prolonged cytopenia after cladribine treatment in relapsed patients with indolent non-Hodgkin's lymphomas: results of a Japanese phase II study.
Topics: Adult; Aged; Cladribine; Female; Humans; Japan; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mycosis Fungoides; Myelodysplastic Syndromes; Neoplasms, Second Primary; Pancytopenia; Recurrence; Remission Induction; Salvage Therapy; Survival Analysis | 2004 |
Prolonged clinical remission in patients with extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type treated with cladribine: 6 year follow-up of a phase II trial.
Topics: Antineoplastic Agents; Cladribine; Follow-Up Studies; Humans; Lymphoma, B-Cell; Lymphoma, B-Cell, Marginal Zone; Remission Induction; Survival Analysis | 2006 |
Randomized comparison of cladribine alone or in combination with cyclophosphamide, and cyclophosphamide, vincristine and prednisone in previously untreated low-grade B-cell non-Hodgkin lymphoma patients: final report of the Polish Lymphoma Research Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cladribine; Cyclophosphamide; Disease Progression; Female; Humans; Lymphoma, B-Cell; Male; Middle Aged; Neoplasm Staging; Poland; Prednisone; Survival Rate; Vincristine | 2008 |
Lack of efficacy of 2-chlorodeoxyadenoside in the treatment of splenic lymphoma with villous lymphocytes.
Topics: Adenosine Triphosphate; Aged; Antineoplastic Agents; Cladribine; Cohort Studies; Disease-Free Survival; Female; Follow-Up Studies; Humans; Lymphoma, B-Cell; Male; Middle Aged; Recurrence; Splenic Neoplasms; Therapeutic Equivalency; Treatment Outcome | 2000 |
14 other study(ies) available for cladribine and Lymphoma, B-Cell
| Article | Year |
|---|---|
Concurrent chronic lymphocytic leukemia/small lymphocytic lymphoma and hairy cell leukemia: clinical, pathologic and molecular features.
Topics: Cladribine; Humans; Leukemia, Hairy Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, B-Cell; Rituximab | 2020 |
Cladribine treatment in two-hour intravenous infusion for previously-treated low grade B-cell lymphoma: a pilot study.
Topics: Adult; Aged; Ambulatory Care; Antineoplastic Agents; Asian People; Cladribine; Female; Humans; Infusions, Intravenous; Japan; Lymphoma, B-Cell; Male; Middle Aged; Pilot Projects; Recurrence; Retrospective Studies | 2009 |
Comprehensive proteomic analysis of the effects of purine analogs on human Raji B-cell lymphoma.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cladribine; Electrophoresis, Gel, Two-Dimensional; Endoplasmic Reticulum; Endoplasmic Reticulum Chaperone BiP; Humans; Lymphoma, B-Cell; Mitochondria; Molecular Chaperones; Proteome; Purines; Vidarabine | 2011 |
Epstein-Barr virus-associated B-cell non-Hodgkin lymphoma following treatment of hairy cell leukemia with cladribine.
Topics: Antineoplastic Agents; Cladribine; Epstein-Barr Virus Infections; Humans; Leukemia, Hairy Cell; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Neoplasms, Second Primary | 2003 |
[Cladribine monotherapy for patients with relapsed or refractory indolent non-Hodgkin lymphoma].
Topics: Aged; Antineoplastic Agents; Cladribine; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Lymphoma, B-Cell; Male; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Treatment Outcome | 2004 |
Richter's syndrome in the brain first manifested as an ischaemic stroke.
Topics: Brain; Brain Ischemia; Brain Neoplasms; Cell Transformation, Neoplastic; Cladribine; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Syndrome | 2004 |
Inhibition of the ERK pathway promotes apoptosis induced by 2-chloro-2'-deoxyadenosine in the B-cell leukemia cell line EHEB.
Topics: Antineoplastic Agents; Apoptosis; Caspase 3; Cell Line, Tumor; Cladribine; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Humans; Inhibitory Concentration 50; Lymphoma, B-Cell; Phosphorylation | 2006 |
[Successful salvage therapy with cladribine and rituximab for a patient with a relapsed Asian variant of intravascular large B-cell lymphoma].
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Drug Administration Schedule; Humans; Lymphoma, B-Cell; Male; Recurrence; Rituximab; Salvage Therapy; Vascular Neoplasms | 2006 |
Clinical problem-solving: costly errors.
Topics: Anemia, Hemolytic, Autoimmune; Antineoplastic Agents; Cladribine; Humans; Immunoglobulin M; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse | 1995 |
Comparative effects of cladribine, fludarabine and pentostatin on nucleotide metabolism in T- and B-cell lines.
Topics: Adenosine Deaminase Inhibitors; Antibiotics, Antineoplastic; Antineoplastic Agents; Cell Division; Cladribine; Deoxyribonucleotides; Enzyme Inhibitors; Humans; Kinetics; Leukemia, T-Cell; Lymphoma, B-Cell; Pentostatin; Ribonucleotides; Tumor Cells, Cultured; Vidarabine | 1998 |
Cytotoxicity of 2-chlorodeoxadenosine (cladribine, 2-cdA) in combination with other chemotherapy drugs against two lymphoma cell lines.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Survival; Chlorambucil; Cisplatin; Cladribine; Drug Screening Assays, Antitumor; Etoposide; Humans; Lymphoma, B-Cell; Paclitaxel; Tumor Cells, Cultured | 1999 |
Epstein-Barr virus-associated lymphoma after treatment of macroglobulinemia with cladribine.
Topics: Aged; Cladribine; Fatal Outcome; Female; Herpesvirus 4, Human; Humans; Immunosuppressive Agents; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Waldenstrom Macroglobulinemia | 1999 |
Richter's syndrome following cladribine therapy for chronic lymphocytic leukemia first manifested as pathologic fracture of the femur.
Topics: Aged; Bone Marrow; Cell Transformation, Neoplastic; Cladribine; Femoral Fractures; Humans; Karyotyping; Leukemia, Lymphocytic, Chronic, B-Cell; Lymph Nodes; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Neoplasms, Second Primary; Radionuclide Imaging; Syndrome | 2001 |
Anti-CD20 antibody (IDEC-C2B8, rituximab) enhances efficacy of cytotoxic drugs on neoplastic lymphocytes in vitro: role of cytokines, complement, and caspases.
Topics: Amino Acid Chloromethyl Ketones; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antigens, Neoplasm; Antineoplastic Agents; Apoptosis; Bendamustine Hydrochloride; Burkitt Lymphoma; Caspase 7; Caspase 8; Caspase 9; Caspase Inhibitors; Caspases; Cladribine; Complement Activation; Complement System Proteins; Cysteine Proteinase Inhibitors; Doxorubicin; Drug Synergism; Gene Expression Regulation, Leukemic; Gene Expression Regulation, Neoplastic; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Interleukins; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, B-Cell; Lymphoma, Follicular; Mitoxantrone; Neoplasm Proteins; Nitrogen Mustard Compounds; Oligopeptides; Rabbits; Rituximab; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 2002 |